neuroendocrine carcinoma

From Aaushi
Jump to navigation Jump to search

Pathology

Radiology

Management

* a radionuclide linked to a somatostatin analogue targets somatostatin receptor- expressing neuroendocrine tumors

More general terms

More specific terms

Additional terms

References

  1. Jump up to: 1.0 1.1 1.2 1.3 1.4 1.5 Medical Knowledge Self Assessment Program (MKSAP) 17, 18. American College of Physicians, Philadelphia 2015, 2018.
  2. Jump up to: 2.0 2.1 Reidy DL, Tang LH, Saltz LB. Treatment of advanced disease in patients with well- differentiated neuroendocrine tumors. Nat Clin Pract Oncol. 2009 Mar;6(3):143-52. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19190591
  3. Jump up to: 3.0 3.1 Kipnis ST, Hung M, Kumar S et al Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors. JAMA Netw Open. 2021;4(3):e212274 March 23 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33755166 Free article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777778